Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
Buffalo Local Index
Buffalo Local Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
265.30
+0.34 (+0.13%)
Streaming Delayed Price
Updated: 12:48 PM EDT, Aug 24, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,200,168
Open
263.99
Bid (Size)
265.25 (100)
Ask (Size)
265.35 (100)
Prev. Close
264.96
Today's Range
262.07 - 265.63
52wk Range
190.75 - 267.47
Shares Outstanding
N/A
Dividend Yield
2.61%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Billionaire Ken Griffin Just Loaded Up on AbbVie and Abbott. Here's Whether Investors Should Follow His Lead.
↗
Today 10:35 EDT
AbbVie and Abbott stand out as strong healthcare investments because they combine established businesses with long-term growth opportunities.
Via
The Motley Fool
Topics
Intellectual Property
2 Dividend Stocks to Buy and Never Sell
↗
August 23, 2026
Both of these healthcare leaders are Dividend Kings.
Via
The Motley Fool
Topics
Economy
Performance
YTD
+15.7%
+15.7%
1 Month
+2.3%
+2.3%
3 Month
+24.5%
+24.5%
6 Month
+15.6%
+15.6%
1 Year
+27.8%
+27.8%
More News
Read More
The Dividend ETF That Generates Passive Income While You Sleep
↗
August 21, 2026
Via
The Motley Fool
Topics
ETFs
3 Unpopular Stocks That Deserve Some Love
August 21, 2026
Via
StockStory
Topics
Energy
Vertex Pharmaceuticals' Rally Has a New Engine -- and Wall Street Thinks the Best Is Still Ahead
↗
August 20, 2026
Via
The Motley Fool
Plastic Surgeon Dr. Young Cho Named to National MD Codes Faculty
August 19, 2026
Via
Press Advantage
Billionaire Ken Griffin Increased His Position in This Dividend King by 547%
↗
August 19, 2026
Via
The Motley Fool
Topics
Intellectual Property
A New Category Is Forming in Medical Aesthetics. Independent Research Has Started Sizing It.
August 18, 2026
From
Equity Insider
Via
GlobeNewswire
2 Dividend Stocks That Are No-Brainer Buys in August
↗
August 18, 2026
Via
The Motley Fool
Topics
Economy
Intellectual Property
Neuroscience Is Becoming AbbVie's Quiet Powerhouse -- and Management Now Sees $12.7 Billion in Sales This Year
↗
August 16, 2026
Via
The Motley Fool
Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
↗
August 14, 2026
Via
The Motley Fool
AbbVie vs. Bristol-Myers Squibb: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 14, 2026
Via
The Motley Fool
Topics
Intellectual Property
The GLP-1 Boom Created a Tissue Gap Fillers Were Not Built For
August 12, 2026
From
USA News Group
Via
GlobeNewswire
2 Reasons to Like ABBV and 1 to Stay Skeptical
August 12, 2026
Via
StockStory
Topics
Stocks
Supply Chain
AbbVie vs. CVS Health: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 11, 2026
Via
The Motley Fool
Pfizer vs AbbVie: What's the Better Dividend Stock for Investors in 2026?
↗
August 11, 2026
Via
The Motley Fool
Topics
Stocks
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry?
↗
August 11, 2026
Via
The Motley Fool
Is AbbVie Stock a Buy After Posting Strong Q2 Earnings?
↗
August 10, 2026
Via
The Motley Fool
Vanguard Health Care ETF vs State Street XLV: Which ETF Is the Better Buy for Investors in 2026?
↗
August 08, 2026
Via
The Motley Fool
Topics
ETFs
Economy
MarketBeat Week in Review – 08/03 - 08/07
↗
August 08, 2026
Via
MarketBeat
Topics
Economy
Intellectual Property
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026?
↗
August 07, 2026
Via
The Motley Fool
Could 1 Tiny Biotech Topple Vertex Pharmaceuticals' Cystic Fibrosis Empire?
↗
August 07, 2026
Via
The Motley Fool
The 5 Most Interesting Analyst Questions From AbbVie’s Q2 Earnings Call
August 07, 2026
Via
StockStory
Topics
Earnings
3 Cash-Producing Stocks for Long-Term Investors
August 06, 2026
Via
StockStory
Topics
Energy
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now
↗
August 05, 2026
Via
The Motley Fool
Topics
Intellectual Property
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 265.30
When was AbbVie last traded?
The last trade of AbbVie was at 08/24/26 12:48 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.